BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 6977138)

  • 21. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
    Beyer-Enke SA; Strauss LG; Georgi M
    Strahlenther Onkol; 1986 Jul; 162(7):441-7. PubMed ID: 3488595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Perioperative changes of complement (C1q, C3, C4) with cardiopulmonary bypass].
    Wang YT; Xu JX; Zhu YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):86-8, 126-7. PubMed ID: 3264237
    [No Abstract]   [Full Text] [Related]  

  • 23. The classical complement pathway: mechanism of activation of the first component by antigen-antibody complexes.
    Loos M
    Prog Allergy; 1982; 30():135-92. PubMed ID: 7041131
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recurrent post-infectious immune complex glomerulonephritis with persistent activation of the alternative complement pathway].
    Arslan-Kirchner M; Ehrich JH; Kirschfink M; Helmchen U; Brodehl J
    Monatsschr Kinderheilkd; 1990 Feb; 138(2):81-4. PubMed ID: 2138710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Activation of the complement system during chronic hemodialysis].
    Rus HG; Cristea A; Gherman M; Manasia M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(3):275-81. PubMed ID: 6138841
    [No Abstract]   [Full Text] [Related]  

  • 26. The significance of complement in proliferative vitreoretinopathy.
    Grisanti S; Wiedemann P; Weller M; Heimann K; Zilles K
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2711-7. PubMed ID: 1894471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An appraisal of third complement component (C3) and breakdown product (C3d) in erythema nodosum leprosum (ENL).
    Saha K; Chakraborty AK; Sharma V; Sehgal VN
    Lepr Rev; 1982 Dec; 53(4):253-60. PubMed ID: 6984124
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduction of phagocyte adherence by nephritic sera: relation to complement activation.
    Strife CF; Ruley EJ
    Pediatr Res; 1984 Jul; 18(7):637-42. PubMed ID: 6332298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-obstructive nephrolithiasis: metabolic and immunopathological studies.
    Jeantet A; Tetta C; Camussi G; Ferrando U; Rotunno M; Thea A; Gaido M; Vercellone A
    Contrib Nephrol; 1985; 49():123-7. PubMed ID: 3913569
    [No Abstract]   [Full Text] [Related]  

  • 30. [Activation of the complement system in the course of chronic hemodialysis].
    Rus HG; Cristea A; Gherman M; Manasia M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(3):275-81. PubMed ID: 6132439
    [No Abstract]   [Full Text] [Related]  

  • 31. Structure and function of membrane complement receptors. Summary.
    Ross GD
    Fed Proc; 1982 Dec; 41(14):3089-93. PubMed ID: 6982833
    [No Abstract]   [Full Text] [Related]  

  • 32. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different patterns of C3 and C4 activation in the varied types of juvenile arthritis.
    Miller JJ; Olds LC; Silverman ED; Milgrom H; Curd JG
    Pediatr Res; 1986 Dec; 20(12):1332-7. PubMed ID: 3099253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of the C1q binding assay in the analysis of immune complexes: personal experiences with its clinical use and future prospectives].
    Corvetta A; Spaeth PJ; Panico F; Ghirelli PA; Orecchioni F; Danieli G
    G Clin Med; 1983; 64(9-10):337-48. PubMed ID: 6198235
    [No Abstract]   [Full Text] [Related]  

  • 36. [Estimating the participation of the classical and alternative ways of complement activation in the immunodiagnosis of glomerulonephritis (author's transl)].
    Sasinka M; Páleníková O; Pavlovic M; Getlík A; Kaiserová E
    Cas Lek Cesk; 1978; 117(44-45):1383-6. PubMed ID: 728923
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunological studies of human placentae: complement components in pre-eclamptic chorionic villi.
    Sinha D; Wells M; Faulk WP
    Clin Exp Immunol; 1984 Apr; 56(1):175-84. PubMed ID: 6370518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of immunocomplexes and complement in renal transplantation. Preliminary data].
    Schena FP; Pertosa G; Manno C; Losuriello V; Pastore A
    Minerva Chir; 1980 May; 35(10):709-14. PubMed ID: 7005726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro complement activation by intercellular antibodies.
    Hashimoto T; Sugiura M; Kurihara S; Nishikawa T
    J Invest Dermatol; 1982 Apr; 78(4):316-8. PubMed ID: 6978365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating immune complexes and complement levels in hemophilic children.
    Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
    J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.